8-K ·Filed Jul 2, 2026

PHGE

BiomX Inc.
BEARISH
Impact 6/10
Horizonweeks Processed3mo ago SEC0001213900-26-075072
8-K material event: Items 4.01
Actionable Insight ▼ Bearish

Auditor change from Big 4 (PwC) to a smaller Israeli firm (Barzily) amid a going-concern qualification is a classic distress signal. Monitor the next 10-Q for any further going-concern deterioration, cash runway disclosures, and potential NYSE American continued listing requirements. The PwC letter agreeing with the statements somewhat mitigates disagreement risk, but the combination of micro-cap status, going-concern warning, and auditor downgrade is bearish.

DirectionBearish
Confidencemedium
Horizonweeks
Latest settled — T+20d
PHGE ▼ -40.81% at T+20d
SHORT call ✓ call won +40.81% · α vs SPY +40.40% · entry $0.3190 → $0.1888
Next anchor: T+60d due 5d ago
Latest observation: T+56 -183.18% FF3 residual α
Entry anchored
Jul 2, 03:44 PM ET
via exchange tick
T+1d
-5.33%
call +5.33% · α +6.20%
$0.3020
settled 3mo ago
T+5d
-12.23%
call +12.23% · α +13.16%
$0.2800
settled 3mo ago
T+20d
-40.81%
call +40.81% · α +40.40%
$0.1888
settled 2mo ago
T+60d
—
call — · α —
—
due 5d ago

Price Chart

Loading chart...

Executive Summary

BiomX Inc. (PHGE, $4M market cap) dismissed PwC and engaged Barzily & Co. as its new auditor, effective July 1, 2026. PwC's audit reports for FY2024 and FY2025 included going-concern qualifications, and no disagreements or reportable events were disclosed. While the switch from a Big 4 firm to a smaller Israeli firm is a red flag, the filing states no disagreements and the old auditor agreed with the disclosures, making this a routine change on paper, though the going-concern paragraph amplifies distress risk.

Key Facts

  • PwC (Kesselman & Kesselman) was dismissed as auditor effective July 1, 2026.
  • Barzily & Co. was engaged as the new independent auditor as of July 1, 2026.
  • PwC's audit reports for FY2024 and FY2025 each included a going-concern explanatory paragraph.
  • No disagreements or reportable events occurred between BiomX and PwC during the covered periods.
  • PwC agreed with the company's statements via Exhibit 16.1 letter to the SEC.
  • The company's market cap is approximately $4 million, and it trades on NYSE American.

Financial Impact

No financial figures were provided in the filing; known metrics: market cap ~$4M.

going_concern_risk

Risk Factors

  • Going-concern qualification persists, indicating possible inability to continue operations within 12 months.
  • Downsizing to a smaller auditor may reduce audit quality perception and disadvantage financing efforts.
  • Micro-cap ($4M) suggests limited financial flexibility and high vulnerability to adverse events.
  • NYSE American listing may be at risk if stockholders' equity falls below required minimums.

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
75% bullish (8 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-075072
Document: ea029693401ex16-1.htm0001213900-26-075072
Document: 0001213900-26-075072-index-headers.html0001213900-26-075072
Document: 0001213900-26-075072-index.html0001213900-26-075072
Document: 0001213900-26-075072.txt0001213900-26-075072
20 reports for PHGE
Performance horizon
60% Hit rate 6 of 10 directional calls best @ T+20▲ +62.36%Jun 16, 2026
Filters
Rows
Reports for PHGE — sortable, filterable
TypeNow
Sep 1, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$0.1425 $1.85▲ +1198.25%▲ +1199.20%$0.3600 (+152.63%)
Aug 28, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$0.1371 $0.1550▲ +13.06%▲ +13.20%$0.3600 (+162.58%)
Aug 5, 2026
8w ago
Press Release
BEARISH ★ 5/10
$0.1800 $0.1483▲ +17.61%▲ +17.96%$0.3600 (−100.00%)
Jul 28, 2026
9w ago
8-K
BEARISH ★ 8/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 28, 2026
9w ago
Press Release
BEARISH ★ 7/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 27, 2026
9w ago
424B5
BEARISH ★ 7/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 8, 2026
12w ago
Press Release
NEUTRAL ★ 4/10
$0.2758 $0.2100▼ −23.86%▼ −24.72%$0.3600 (+30.53%)
Jul 2, 2026
13w ago
8-K
BEARISH ★ 6/10
$0.3190 $0.2800▲ +12.23%▲ +13.16%$0.3600 (−12.85%)
Jun 29, 2026
13w ago
S-1
BEARISH ★ 5/10
$0.3478 $0.3020▲ +13.17%▲ +13.77%$0.3600 (−3.51%)
Jun 22, 2026
14w ago
DEFA14A
NEUTRAL ★ 2/10
$0.4615 $0.3590▼ −22.21%▼ −23.22%$0.3600 (−21.99%)
Showing 10 of 20

US Market Status

Market Closed — Opens Mon (33h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access